GALDERMA LABORATORIES, L.P.

Lobbying client · Massachusetts · filed 2026 to 2026

Pharmaceutical company specializing in dermatological treatments.

$30,000 Reported spend

2 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 2 filings. Everything on this page is grouped by the client's LDA id (74303), not by name.

Firms hired 1

DLA PIPER LLP (US) $30,000 2 filings

Reported by year 1 year

2026 $30,000 2 filings

Issues lobbied 2

Pharmacy 2
Trade (domestic/foreign) 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

Executive Office of the President (EOP) 1
HOUSE OF REPRESENTATIVES 1

Recent filings 2 total

Q2

DLA PIPER LLP (US)

2nd Quarter (Apr 1 - June 30) 2026 · House · $30,000 income · posted Aug 6, 2026

View → RR

DLA PIPER LLP (US)

2nd Quarter (Apr 1 - June 30) 2026 · posted Jul 23, 2026

View →

Foreign entities disclosed 2

GALDERMA GROUP AG Switzerland named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0
L'OREAL GROUPE France named on 1 filing · highest disclosed ownership 20% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.